Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.
…
continue reading
Content provided by Mind Manifest Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mind Manifest Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
EP 6 JESSICA ZITTER
MP3•Episode home
Manage episode 260018915 series 2661020
Content provided by Mind Manifest Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mind Manifest Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, I spoke with Dr Jesscia Zitter. She first came to my attention after I read New York Times article, which crystallised the dissonance and conflict I suspect a lot of critical care physicians feel around the marshalling of the end of life for their patients. The ‘slow burn’ of psychedelic science is as it should be – the gradual percolation of their empirically ratified benefits through medicine and then hopefully into mainstream society. At the time of writing, the research into the therapeutic benefits of psilocybin in end-of-life care, for example, seems to be proceeding at a pace that Goldilocks would approve of - not excessively slowed down by obfuscating bureaucrats, nor impatiently pushed along by overzealous stakeholders and evangelists. This gives us time to have a cultural conversation about how we can best integrate these substances into the care of the dying. If the phase 3 trials for psilocybin and other psychedelics in the fields of palliative care produce a shade of the benefits seen in phase 2, then the proposition of their normative prescription of psychedelics for end of life issues will move from the realms of absolute psychonaut fantasy to possible medical reality. Furthermore, (Barring some massive paradigm shift in the nature of health care hierarchy), doctors will very likely spearhead the prescription of such substances to the dying, and as such, I wanted to get a ‘physicians eye view’ of the current state of play in the world of palliative medicine - and that’s where Jessica comes in. She speaks with a nice combination of candour and humour, with confidence and doubt. I hope you enjoy.
…
continue reading
34 episodes
MP3•Episode home
Manage episode 260018915 series 2661020
Content provided by Mind Manifest Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mind Manifest Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode, I spoke with Dr Jesscia Zitter. She first came to my attention after I read New York Times article, which crystallised the dissonance and conflict I suspect a lot of critical care physicians feel around the marshalling of the end of life for their patients. The ‘slow burn’ of psychedelic science is as it should be – the gradual percolation of their empirically ratified benefits through medicine and then hopefully into mainstream society. At the time of writing, the research into the therapeutic benefits of psilocybin in end-of-life care, for example, seems to be proceeding at a pace that Goldilocks would approve of - not excessively slowed down by obfuscating bureaucrats, nor impatiently pushed along by overzealous stakeholders and evangelists. This gives us time to have a cultural conversation about how we can best integrate these substances into the care of the dying. If the phase 3 trials for psilocybin and other psychedelics in the fields of palliative care produce a shade of the benefits seen in phase 2, then the proposition of their normative prescription of psychedelics for end of life issues will move from the realms of absolute psychonaut fantasy to possible medical reality. Furthermore, (Barring some massive paradigm shift in the nature of health care hierarchy), doctors will very likely spearhead the prescription of such substances to the dying, and as such, I wanted to get a ‘physicians eye view’ of the current state of play in the world of palliative medicine - and that’s where Jessica comes in. She speaks with a nice combination of candour and humour, with confidence and doubt. I hope you enjoy.
…
continue reading
34 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.